Lilly, Amylin Disclose More Cases of Byetta-Related Pancreatitis

Posted by Shirley S. Wang in WSJ Health blog Last week, the FDA said it had received reports of six new cases of pancreatitis – including two deaths – associated with the diabetes drug Byetta. Today, Amylin and Eli Lilly said that they had reported four additional deaths to the agency as well, which the FDA hasn’t yet made public.